Market Research Logo

Sigmoid Pharma Limited - Product Pipeline Review - 2016

Sigmoid Pharma Limited - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Sigmoid Pharma Limited - Product Pipeline Review - 2016’, provides an overview of the Sigmoid Pharma Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sigmoid Pharma Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Sigmoid Pharma Limited
  • The report provides overview of Sigmoid Pharma Limited including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sigmoid Pharma Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sigmoid Pharma Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Sigmoid Pharma Limited’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sigmoid Pharma Limited
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sigmoid Pharma Limited’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Sigmoid Pharma Limited Snapshot
Sigmoid Pharma Limited Overview
Key Information
Key Facts
Sigmoid Pharma Limited - Research and Development Overview
Key Therapeutic Areas
Sigmoid Pharma Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Sigmoid Pharma Limited - Pipeline Products Glance
Sigmoid Pharma Limited - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Sigmoid Pharma Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sigmoid Pharma Limited - Drug Profiles
cyclosporine CR
Product Description
Mechanism of Action
R&D Progress
cyclosporine
Product Description
Mechanism of Action
R&D Progress
cyclosporine CR + cyclosporine IR
Product Description
Mechanism of Action
R&D Progress
cyclosporine IR
Product Description
Mechanism of Action
R&D Progress
calcitonin
Product Description
Mechanism of Action
R&D Progress
dimethyloxalylglycine
Product Description
Mechanism of Action
R&D Progress
Helicobacter pylori [strain Hel-305] (multivalent) vaccine
Product Description
Mechanism of Action
R&D Progress
celecoxib
Product Description
Mechanism of Action
R&D Progress
Drugs for Gastrointestinal and Immunological Disorders
Product Description
Mechanism of Action
R&D Progress
Drugs to Agonize FXR for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Sigmoid Pharma Limited - Pipeline Analysis
Sigmoid Pharma Limited - Pipeline Products by Target
Sigmoid Pharma Limited - Pipeline Products by Route of Administration
Sigmoid Pharma Limited - Pipeline Products by Molecule Type
Sigmoid Pharma Limited - Pipeline Products by Mechanism of Action
Sigmoid Pharma Limited - Recent Pipeline Updates
Sigmoid Pharma Limited - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sigmoid Pharma Limited, Key Information
Sigmoid Pharma Limited, Key Facts
Sigmoid Pharma Limited - Pipeline by Indication, 2016
Sigmoid Pharma Limited - Pipeline by Stage of Development, 2016
Sigmoid Pharma Limited - Monotherapy Products in Pipeline, 2016
Sigmoid Pharma Limited - Combination Treatment Modalities in Pipeline, 2016
Sigmoid Pharma Limited - Phase II, 2016
Sigmoid Pharma Limited - Phase I, 2016
Sigmoid Pharma Limited - Preclinical, 2016
Sigmoid Pharma Limited - Discovery, 2016
Sigmoid Pharma Limited - Pipeline by Target, 2016
Sigmoid Pharma Limited - Pipeline by Route of Administration, 2016
Sigmoid Pharma Limited - Pipeline by Molecule Type, 2016
Sigmoid Pharma Limited - Pipeline Products by Mechanism of Action, 2016
Sigmoid Pharma Limited - Recent Pipeline Updates,
List of Figures
Sigmoid Pharma Limited - Pipeline by Top 10 Indication, 2016
Sigmoid Pharma Limited - Pipeline by Stage of Development, 2016
Sigmoid Pharma Limited - Monotherapy Products in Pipeline, 2016
Sigmoid Pharma Limited - Pipeline by Target, 2016
Sigmoid Pharma Limited - Pipeline by Route of Administration, 2016
Sigmoid Pharma Limited - Pipeline by Molecule Type, 2016
Sigmoid Pharma Limited - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report